#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Conjunctivitis allergic Myelodysplastic syndrome with excess blasts Albright's disease Synovitis Inborn error of metabolism Neovascular age-related macular degeneration Hypochromic anaemia Bile acid synthesis disorder Lupus nephritis Narcolepsy Kaposi's sarcoma Frostbite Leukocyte adhesion deficiency type I Malignant fibrous histiocytoma Prostate cancer More trials…

    Learn about Rare Diseases

    Haemolytic uraemic syndrome Usher’s syndrome – Life with Disease Haemophilia A with anti factor VIII – Trials in Disease Mantle cell lymphoma Ewing’s sarcoma recurrent – Trials in Disease Behcet’s syndrome – Diagnostics Pelizaeus-Merzbacher disease – Treatment Mucous membrane pemphigoid VEXAS syndrome – Basic Information Methylmalonic acidaemia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tiotropium Bromide Tanimilast Lufepirsen Tildrakizumab Posdinemab Lenalidomide ILOPROST Dutasteride Isoleucine Clemastine Sacituzumab Tirumotecan Benzylpenicillin Sodium Eribulin Mesylate Sertindole Niraparib Tosilate Monohydrate Florquinitau (18F) Alteplase Dog Epithelia Hydrocortisone Ph. Eur. F44/10 More therapies…

    Learn about Your Condition

    Phenylketonuria Eosinophilic oesophagitis Endometrial cancer Metastases to rectum Fragile X syndrome Blood iron increased Mitral valve incompetence Dent's disease Adrenocortical carcinoma Bile duct adenocarcinoma Bacteraemia Loeys-Dietz syndrome Premature rupture of membranes Congenital pseudarthrosis Radius fracture More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Phase 2b Randomized Double‑Blind Study of Oral PF‑08049820 in Adults with Moderate to Severe Atopic Dermatitis

    Not yet recruiting

    2 1
    Bulgaria Czechia France Germany Poland

  • Evaluating measles, mumps, rubella vaccine (live) in lactating women to enhance infant mucosal immunity

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Measles Virus Edmonston-Enders Strain (Live, Attenuated) Produced In Chick Embryo Cells
    • Mumps Virus Jeryl Lynn (Level B) Strain (Live, Attenuated) Produced In Chick Embryo Cells
    • Rubella Virus Wistar Ra 27/3 Strain (Live, Attenuated) Produced In Wi-38 Human Diploid Lung Fibroblasts
    Belgium

  • Feasibility, Tolerability and Adherence of Alternate-Day Ferrous Sulfate (Duroferon) in Adolescent Girls With Iron Deficiency

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Iron deficiency
    Investigated Drugs:
    • Ferrous Sulfate
    Sweden

  • Study of teclistamab plus autologous lymphocyte infusion in patients with relapsed or refractory multiple myeloma

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Teclistamab
    Italy

  • Safety and Preliminary Efficacy of Oral GSK5460025A Alone or with Drug Combination in Adult Patients with dMMR/MSI‑H Colorectal Cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • GSK5460025A
    Denmark France Italy The Netherlands Spain Sweden

  • Comparing local gentamicin or vancomycin hydrochloride to a drug combination for patients with diabetic foot osteomyelitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Diabetic foot
    • Osteomyelitis
    Investigated Drugs:
    • Amoxicillin Trihydrate
    • Cefalexin Monohydrate
    • Flucloxacillin
    Finland
Previous Page
1 … 722 723 724 725 726 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!